Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline

INTRODUCTION: Currently, cabergoline therapy is the main treatment for prolactinomas. The use of the drug in most cases leads to regression of the tumor, normalization of prolactin (PRL) levels, and restoration of gonadotropic function. The mechanism of its action in tumor cells “in vivo” tracked in...

Descripción completa

Detalles Bibliográficos
Autores principales: Astaf’eva, Ludmila, Shishkina, Ludmila, Kalinin, Pavel, Kadashev, Boris, Melnichenko, Galina, Tserkovnay, Dariia, Sharipov, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335146/
https://www.ncbi.nlm.nih.gov/pubmed/32656137
http://dx.doi.org/10.4103/ajns.AJNS_16_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335146/
https://www.ncbi.nlm.nih.gov/pubmed/32656137
http://dx.doi.org/10.4103/ajns.AJNS_16_20

Ejemplares similares